Human blood dendritic cell antigen 3 (BDCA3)+ dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus

Hepatology

Volumn 57, Issue 5, 2013, Pages 1705-1715

  Yoshio, Sachiyo ^a   Kanto, Tatsuya ^a   Kuroda, Shoko ^a   Matsubara, Tokuhiro ^a   Higashitani, Koyo ^a   Kakita, Naruyasu ^a   Ishida, Hisashi ^a   Hiramatsu, Naoki ^a   Nagano, Hiroaki ^b   Sugiyama, Masaya ^c   Murata, Kazumoto ^c   Fukuhara, Takasuke ^d   Matsuura, Yoshiharu ^d   Hayashi, Norio ^e   Mizokami, Masashi ^c   Takehara, Tetsuo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e KANSAI ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN A1; BLOOD DENDRITIC CELL ANTIGEN 3; CD123 ANTIGEN; CD81 ANTIGEN; CELL ANTIGEN; CHLOROQUINE; GLYCOPROTEIN P 15095; INTERLEUKIN 28B; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL CULTURE; CELL STIMULATION; CYTOKINE RELEASE; ENDOSOME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSFECTION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INNATE IMMUNITY; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MYELOID DENDRITIC CELL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRAVIOLET IRRADIATION; VIRUS REPLICATION;

ADULT; ANTIGENS, SURFACE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; GENOTYPE; HEPACIVIRUS; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LIVER; LIVER NEOPLASMS; MALE; PHENOTYPE; POLY I-C;

EID: 84876700100     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26182     Document Type: Article

References (27)

1. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 2009; 41: 1100-1104.
2. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009; 41: 1105-1109.
3. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461: 399-401.
4. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461: 798-801.
5. Kotenko SV. IFN-lambdas. Curr Opin Immunol 2011; 23: 583-590.
6. Urban TJ, Thompson AJ, Bradrick SS, Fellay J, Schuppan D, Cronin KD, et al. IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. HEPATOLOGY 2010; 52: 1888-1896.
7. Park H, Serti E, Eke O, Muchmore B, Prokunina-Olsson L, Capone S, et al. IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection. HEPATOLOGY 2012; 56: 2060-2070.
8. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007; 449: 819-826.
9. Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001; 106: 259-262.
10. Poulin LF, Salio M, Griessinger E, Anjos-Afonso F, Craciun L, Chen JL, et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J Exp Med 2010; 207: 1261-1271.
11. Lauterbach H, Bathke B, Gilles S, Traidl-Hoffmann C, Luber CA, Fejer G, et al. Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J Exp Med 2010; 207: 2703-2717.
12. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11: 791-796.
13. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309: 623-626.
14. Mori Y, Okabayashi T, Yamashita T, Zhao Z, Wakita T, Yasui K, et al. Nuclear localization of Japanese encephalitis virus core protein enhances viral replication. J Virol 2005; 79: 3448-3458.
15. Sugiyama M, Kimura T, Naito S, Mukaide M, Shinauchi T, Ueno M, et al. Development of interferon lambda 3 specific quantification assay for its mRNA and serum/plasma specimens. Hepatol Res 2012; 42: 1089-1099.
16. Schreibelt G, Klinkenberg LJ, Cruz LJ, Tacken PJ, Tel J, Kreutz M, et al. The C type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells. Blood 2012; 119: 2284-2292.
17. Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 2010; 207: 1247-1260.
18. Marukian S, Jones CT, Andrus L, Evans MJ, Ritola KD, Charles ED, et al. Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. HEPATOLOGY 2008; 48: 1843-1850.
19. Liang H, Russell RS, Yonkers NL, McDonald D, Rodriguez B, Harding CV, et al. Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells. J Virol 2009; 83: 5693-5707.
20. Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, McKeating JA. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol 2004; 78: 1448-1455.
21. Blanchard E, Belouzard S, Goueslain L, Wakita T, Dubuisson J, Wychowski C, et al. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol 2006; 80: 6964-6972.
22. de Bouteiller O, Merck E, Hasan UA, Hubac S, Benguigui B, Trinchieri G, et al. Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J Biol Chem 2005; 280: 38133-38145.
23. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004; 16: 3-9.
24. Velazquez VM, Hon H, Ibegbu C, Knechtle SJ, Kirk AD, Grakoui A. Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection. HEPATOLOGY 2012; 56: 2071-2081.
25. Dental C, Florentin J, Aouar B, Gondois-Rey F, Durantel D, Baumert TF, et al. Hepatitis C virus fails to activate NF-kappaB signaling in plasmacytoid dendritic cells. J Virol 2012; 86: 1090-1096.
26. Thomas E, Gonzalez VD, Li Q, Modi AA, Chen W, Noureddin M, et al. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. Gastroenterology 2012; 142: 978-988.
27. Fang J, Hao Q, Liu L, Li Y, Wu J, Huo X, Zhu Y. Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection. J Virol 2012; 86: 1010-1020.